White House-PhRMA Memo Surfaces Again
Wall Street Journal:
Since mid-July, the White House and the drug industry's Washington lobby, PhRMA, have denied any specific agreement that would give the industry big benefits in exchange for its support for President Barack Obama's health care overhaul effort.
But there is an email outlining a four-part deal that industry lobbyists were sending to each other on July 7. The White House and PhRMA have called the memo inaccurate, though one side or the other has acknowledged three of the four big points.







Loading comments…






First Posted: 08-17-09 01:41 PM | Updated: 08-17-09 01:59 PM